ECOG-ACRIN Cancer Research Group/X
Apr 16, 2025, 17:19
Testing a new treatment approach for HNSCC – ECOG-ACRIN Cancer Research Group
ECOG-ACRIN Cancer Research Group shared a post on X:
“April is Head and Neck Cancer Awareness Month!
Clinical Trial EA3191 is testing a new treatment approach for patients with squamous cell carcinoma of the head and neck (HNSCC) that has come back after initial therapy.
More posts featuring ECOG-ACRIN Cancer Research Group.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 18, 2025, 20:22
Apr 18, 2025, 20:12
Apr 18, 2025, 20:03
Apr 18, 2025, 19:54
Apr 18, 2025, 19:49
Apr 18, 2025, 19:44
Apr 18, 2025, 19:26